awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37162216-0BAAE59D-95B5-481F-8C69-4BB36856E6B3
Q37162216-0BAAE59D-95B5-481F-8C69-4BB36856E6B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37162216-0BAAE59D-95B5-481F-8C69-4BB36856E6B3
In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.
P2860
Q37162216-0BAAE59D-95B5-481F-8C69-4BB36856E6B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37162216-0BAAE59D-95B5-481F-8C69-4BB36856E6B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f9758305aff04e5eeb53f40bfc9b42ac537572e
P2860
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.